Showing 1 - 10 of 17
Countries with larger increases in the share of cardiovascular drug doses that contained post-1990 or post-1995 ingredients had smaller increases in the cardiovascular disease hospital discharge rate, controlling for the quantity of cardiovascular medications consumed per person, the use of...
Persistent link: https://www.econbiz.de/10012464639
Does an expansion of patent scope induce more innovative effort by firms? This article provides evidence on this question by examining firm responses to the Japanese patent reforms of 1988. Interviews with practitioners suggest the reforms significantly expanded the scope of patent rights in...
Persistent link: https://www.econbiz.de/10012471730
products to China. We find causal evidence that offshoring impacts both the level and nature of innovation. In the technologies … directly related to product categories that could be offshored more easily after the policy shock, overall innovation levels … decline and innovative effort shifts away from product innovation and towards process innovation. However, we also find …
Persistent link: https://www.econbiz.de/10012616565
I analyze the effects of four types of medical innovation and cancer incidence on U.S. cancer mortality rates during …Under the assumption that there were no pre-dated factors that drove both innovation and mortality and that there would … have been parallel trends in mortality in the absence of innovation, the estimates indicate that there were three major …
Persistent link: https://www.econbiz.de/10012462770
We examine the impact of pharmaceutical innovation on the longevity of Australians during the period 1995-2003. Due to …
Persistent link: https://www.econbiz.de/10012464638
which Northern innovation, Southern imitation, and FDI are all endogenous. Our model predicts that IPR reform in the South …, Northern resources will be reallocated to R&D, driving an increase in the global rate of innovation. We test the model …
Persistent link: https://www.econbiz.de/10012465621
the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of … innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between … pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous …
Persistent link: https://www.econbiz.de/10012466126
higher rates of lab and outpatient innovation had greater declines in the probability of missing work during 1996-2003. This … for initial disability, the inverse relationship between lab innovation and disability changes disappears. This is because … there is a significant inverse relationship between initial health and the extent of laboratory innovation. But due to …
Persistent link: https://www.econbiz.de/10012466549
What is driving the remarkable increase over the last decade in the propensity of patents to cite academic science? Does this trend indicate that stronger knowledge spillovers from academia have helped power the surge in innovative activity in the U.S. in the 1990s? This paper seeks to shed...
Persistent link: https://www.econbiz.de/10012467117
We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to...
Persistent link: https://www.econbiz.de/10012468944